Evidence Hub

Lansoprazole/β-Cyclodextrin-Based Metal-Organic Frameworks: Development, Characterization, and Anti-Ulcer Activity Evaluation on Rats

Alsulays BB

Current drug delivery, 2026

Abstract

INTRODUCTION

Gastric ulcers are among the most common diseases worldwide, affecting individuals of all ages and genders. Lansoprazole (LNS) is one of the first-choice treatments for ulcers. In this study, β-Cyclodextrin-based metal-organic frameworks (β-CD-MOFs), which have recently attracted attention for biomedical applications, were used as carriers for LNS to enhance its physicochemical properties.

METHODS

β-CD-MOF crystals were prepared, and LNS was successfully loaded into the crystals in the presence of MgO. Pure LNS and the formulation were characterized using Differential Scanning Calorimetry (DSC), Powder X-Ray Diffraction (PXRD), Fourier-Transform Infrared spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and in vitro release studies. The anti-ulcer activity was evaluated in male Wistar albino rats.

RESULTS

Dissolution studies revealed that approximately 90% of LNS was released from the formulation within 60 minutes, and the formulation's color remained unchanged after exposure to light. The formulation demonstrated a significant reduction in mucosal erythema and mucosal surface lesions, as well as a higher percentage of ulcer index inhibition.

DISCUSSION

Loading of LNS into β-CD-MOF enhanced its release and photostability. In vivo studies suggest that the formulation has a potent anti-ulcerogenic capability comparable to that of LNS.

CONCLUSION

β-CD-MOF, a promising carrier in drug delivery, improves the properties of LNS and further enhances its…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free